Cover image for Vol. 27 Issue 3

Editor-in-Chief: Professor Minaxi Desai

Impact Factor: 1.481

ISI Journal Citation Reports © Ranking: 2014: 54/76 (Pathology); 160/184 (Cell Biology)

Online ISSN: 1365-2303

Author Guidelines

MANUSCRIPTS should be submitted online at Full instructions and support are available on the site. A user ID and password can be obtained on the first visit. All parts of the manuscript must be available in an electronic format, those recommended are: generic rich text format (RTF) or Microsoft Word for text, and JPEG, GIF, TIFF, EPS, PNG, Microsoft PowerPoint or Excel for graphics. It is recommended that, where possible, all parts of the manuscript be embedded in a single word processer document. *Update (25 May 2012): Please note that we now accept .doc and .docx files.

Support can be contacted by phone (+1 434-817-2040 ext 167), e-mail ( If you cannot submit online, please contact the Editorial Office at (tel: +44 (0) 1603 278046; fax: +44 (0) 1865 714591).

COPYRIGHT If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution License OAA
  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit See section below on Online Open for more information.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit:

ONLINE OPEN OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

EARLYVIEW Cytopathology is covered by Wiley-Blackwell's EarlyView service. EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of EarlyView articles means that they do not yet have volume, issue or page numbers, so EarlyView articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

ETHICAL POLICY AND GUIDELINES Cytopathology encourages its contributors and reviewers to adopt the standards of the International Committee of Medical Journal Editors. The Editors reserve the right to reject a paper that does not meet these standards.
Cytopathology will not consider papers that have been accepted for publication or published elsewhere. Copies of existing manuscripts with potentially overlapping or duplicative material should be submitted together with the manuscript, so that the Editors can judge suitability for publication.

Please click here to read the Ethical Policies of Cytopathology.

For more detailed ethical guidelines please visit:

iThenticateAll Cytopathology papers are checked for potential plagiarism using CrossCheck plagiarism detection software. By submitting your manuscript to Cytopathology you accept that your manuscript will be screened for plagiarism against previously published works.

PATIENT CONFIDENTIALITY AND CONSENT Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Images of, or Information about, Identifiable Individuals: It is the author’s responsibility to obtain consent from patients and other individuals for use of information, images, audio files, interview transcripts, and video clips from which they may be identified. To ensure we have the rights we require please provide a signed consent/release form in all instances.

  • If the person is a minor, consent must be obtained from the child’s parents or guardians.
  • If the person is dead, we consider it essential and ethical that you obtain consent for use from the next of kin. If this is impractical you need to balance the need to use the photo against the risk of causing offence. In all cases ensure you obscure the identity of the deceased.
  • If using older material, or for material obtained in the field, for which signed release forms are, for practical purposes, unobtainable, you will need to confirm in writing that the material in question was obtained with the person’s understanding that it might be published.

GENERAL GUIDELINES All manuscripts should be submitted double spaced in A4 format, with a wide left hand margin. All pages should be numbered in sequence. The first page should by a title page, containing the following information: suggested running headline, author’s name, e-mail address, department, institution, city and country. The MeSH index should be consulted when selecting keywords. Explain all abbreviations on the first usage. There should be no footnotes in the text. Acknowledge any clinical and financial support if appropriate. All submitted manuscripts are subject to peer review and editorial decisions where requires.

For 'Inside this month's Cytopathology', introducing each issue, please provide a short two- or three-sentence description of your manuscript. This can be in the form of an introduction, description or summary of your paper. Please do not use any abbreviations. Please refer to recent issues of the journal for examples.

ORIGINAL ARTICLES Number all pages, beginning with the title page (=1), summary page (=2) etc. The article should be formatted as follows:
Title page: Title of paper, list of authors, affiliations, corresponding author contact details including full address, city, country, and email address.
Abstract: 250 words, structured as follows:
Objective - what was the purpose of the study?
Methods - brief description of materials, patients/subjects and methods used.
Results - what were the main findings?
Conclusions - what are the main conclusions or implications of the study?
Keywords -up to ten keywords should be selected, using terms found at the Medical Subject Headings list from the Index Medicus whenever possible. To access the MESH index, Click Here:
Main paper: this should cover the four main headings shown in the abstract (objective/introduction, methods, results and conclusions).
Word count: approximately 3000 words. Papers that are longer than this may need to be shortened at editorial discretion.
Tables/illustrations: at editorial discretion. See requirements below.

CASE REPORTS Case Report format should include full author details as shown above for an original article, and the main paper should be structured with headings of Case History, Materials and Methods, Results and Discussion. No abstract or keywords are required. Case reports will only be accepted if of exceptional educational interest, value or novelty. Authors may be asked to resubmit their case report in letter format, and must then comply with the letter format shown below.
Word count: up to 1200 words
Introductory paragraph (for all Case reports including those in Letter format): should indicate what is already known about this subject and what this Case Report adds.
Tables/illustrations: no more than two (or one of each). If more than two, the text should be reduced accordingly.
References: up to 10

LETTERS TO THE EDITOR Priority for publication will be given to the letters which are submitted in reference to an article published in the journal within the previous 6 months.
Word count: 800 words
Tables/illustrations: no more than two (or one of each).
References: up to six.

EDITORIAL ARTICLES/REVIEW ARTICLES These will be invited by the editors(s) and must comply with the general guidelines as shown above.

ENIGMA PORTAL CASE OR ARTICLE This section of the journal provides readers with continuing professional development activities. The preferred format for the Enigma Portal section is as follow:
Word count: (e.g. case history, relevant background information): 250 words for the interesting case submitted as quiz and up to 1500 words for the educational article.
Images: Up to four high-qualities TIFF images at a resolution of 300dpi. These must be provided as separate files and not embedded into text documents.
Multiple choice questions (MCQ): up to four, each with a choice of four possible answers
Answers to MCQs: a single sentence explaining each answer
References: up to four
Abstracts and keywords are not required for Enigma Portal content.

FIGURES Figure files should be provided in high-resolution format, separate from the manuscript word document. For graphs and charts, .eps format minimum 800dpi. For photographs or a combination of images and text, .tiff format minimum 300dpi. Figures with multiple parts (A, B, C) or images should be provided separately in their original format. Magnification should be noted rather than inserted on the photographs by scales. Colour photographs are encouraged and will be reproduced without charge to the author.

If you'd like to improve the quality of composite figures made up of graphs, please recreate each part separately using Microsoft PowerPoint. For any graphs that you no longer have the original data to re-plot, please crop the graph portion and re-type all the text and numbers in the figure. You may send us the .ppt file so we can extract the figure. In PowerPoint, any lines in the figures must be at least 1.5 or 2 pts thick. Any text should be in Arial or Times New Roman in minimum 12 or 14 pts.

TABLES should be numbered consecutively by Arabic numerals. All tables and figures must be referred to in the text. Please provide tables and figures as separate files, do not copy and paste them into the manuscript word document. Tables should be in editable format (Microsoft Word / Excel / PowerPoint).

REFERENCES should be in the Vancouver style numbered consecutively in the order in which they first appear in the text. List all authors when there are five or less. When there are six or more authors list only the first three and add et al. Authors are responsible for the accuracy of their references. We recommend the use of a tool such as Reference Manager for reference management and formatting. Reference Manager reference styles can be searched for here:

1. Standard Journal Article
Rice S, Slater DN, Hewer EM. The effect of nonscreening smears on
screening smear results: a statistical analysis with its implications for the
NHS cervical screening programme. Cytopathology 2000;11:158–65.

2. Journal Supplement
Baskin-Bey ES, Morono Luna LE, Gores GJ. Diagnosis of cholangiocarcinoma
in patients with PSC: a sight on cytology. J Hepatol 2006;45(Suppl.1):12–14.

3. Editor, compiler, chairman as author
Dausset J, Colombani J, eds. Histocompatibility Testing. Copenhagen:
Munksgaard; 1973: 12–8.

4. Chapter in a book
Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms.
In: Pathologic Physiology: Mechanisms of Disease, 6th edn.
Sodeman WA Jr. Sodeman WA. (eds). Philadelphia: WB Saunders; 1974:

Cytopathology follows the BMJ house style for spellings, as follows.
A mixture of English and American spelling is permitted, depending on the provenance and main target audience of the article.
practice (noun)
practise (verb)
foetus and fetus are both acceptable in English: the BMJ uses fetus
Please use Whitakers Almanac and Times Gazetteer as sources for geographical names; use European spelling in city names that sound the same as in English (such as Hannover and Lyon).
We allow minimum use of abbreviations because they are hard to read and often the same abbreviation means different things in different specialities and contexts.

PROOFS The corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site: This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof.

OFFPRINTS Free access to the final PDF offprint or your article will be available via Author Services only ( Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. To order offprints of your article, please visit If you have queries about ordering offprints please contact

MATERIAL STORAGE POLICY Unless specifically requested by a society or individual author, hardcopy and electronic materials will be retained for no longer than two months following publication. If you require the return of any material, please inform the editorial office or production editor as soon as possible.

AUTHOR SERVICES enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don’t need to contact the production editor to check on progress. Visit for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

DISCLAIMER The Publisher, the British Society for Clinical Cytology and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, the British Society for Clinical Cytology and Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, the British Society for Clinical Cytology and Editors of the products advertised.